Literature DB >> 30719116

Synchronous primary sigmoid colon cancer and primary thyroid cancer followed by a malignant tumor of the kidney: Case report of multiple primary cancer and review of the literature.

Cheng Peng1,2, Zequn Li1,2, Huijie Gao1,2, Xueqing Zou1,2, Xiao Wang3, Changkuo Zhou4, Jun Niu1,2.   

Abstract

Multiple primary cancer (MPC) is relatively rare. With the development of diagnostic and anti-cancer therapeutic techniques, the incidence of MPC is rising annually. However, the incidence of triple or quadruple cancers in a single patient remains low. In this report, the case of a 58-year-old male with triple malignant cancer is outlined. Synchronous sigmoid colon cancer and thyroid cancer were diagnosed in May 2015; on subsequent re-examination, metastasis to the liver and a malignant kidney tumor were also identified. The diagnosis was established via computed tomography (CT), Positron emission tomography-CT (PET-CT) and other laboratory examination results, including analysis of tumor markers and liver function, and was confirmed by pathological diagnosis. The patient underwent radical surgery and standardized chemotherapy. Through literature review, the definition, characteristics, classification, incidence, possible causes of and treatment strategies for MPC were more clearly understood. In addition, immunohistochemical staining of integrin αvβ6 was performed on patient tissue specimens, where integrin αvβ6 expression was confirmed in cancer of the colon, thyroid and liver, as a result of colonic metastasis. Therefore, the involvement of integrin αvβ6 in the malignant progression of MPC was hypothesized, which may aid the investigation of MPC etiology in the future.

Entities:  

Keywords:  integrin αvβ6; multiple primary cancer

Year:  2018        PMID: 30719116      PMCID: PMC6350185          DOI: 10.3892/ol.2018.9867

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Letter: Five separate malignancies in one patient.

Authors:  P Jones
Journal:  Br Med J       Date:  1976-06-19

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

Authors:  Richard C Bates; David I Bellovin; Courtney Brown; Elizabeth Maynard; Bingyan Wu; Hisaaki Kawakatsu; Dean Sheppard; Peter Oettgen; Arthur M Mercurio
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.

Authors:  A Aydiner; A Karadeniz; K Uygun; S Tas; F Tas; R Disci; E Topuz
Journal:  Am J Clin Oncol       Date:  2000-08       Impact factor: 2.339

5.  The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.

Authors:  M Agrez; X Gu; J Turton; C Meldrum; J Niu; T Antalis; E W Howard
Journal:  Int J Cancer       Date:  1999-03-31       Impact factor: 7.396

6.  Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma.

Authors:  Z-Y Zhang; K-S Xu; J-S Wang; G-Y Yang; W Wang; J-Y Wang; W-B Niu; E-Y Liu; Y-T Mi; J Niu
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-11-05       Impact factor: 4.126

Review 7.  Multiple primary malignant neoplasms: case report and a comprehensive review of the literature.

Authors:  Carlo Greg N Demandante; Dean A Troyer; Toni P Miles
Journal:  Am J Clin Oncol       Date:  2003-02       Impact factor: 2.339

Review 8.  Second cancers after breast cancer treatment.

Authors:  Sister Mary Andrew Matesich; Charles L Shapiro
Journal:  Semin Oncol       Date:  2003-12       Impact factor: 4.929

9.  Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.

Authors:  Guang-Yun Yang; Ke-Sen Xu; Zhong-Qing Pan; Zhao-Yang Zhang; Yue-Tang Mi; Jin-Shen Wang; Rong Chen; Jun Niu
Journal:  Cancer Sci       Date:  2008-02-18       Impact factor: 6.716

10.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.

Authors:  Masashi Ueno; Tetsuichiro Muto; Masatoshi Oya; Hirotoshi Ota; Kaoru Azekura; Toshiharu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2003-06       Impact factor: 3.402

View more
  3 in total

1.  Thyroid and renal cancers: A bidirectional association.

Authors:  Maria Irene Bellini; Eleonora Lori; Flavio Forte; Augusto Lauro; Domenico Tripodi; Maria Ida Amabile; Vito Cantisani; Marzia Varanese; Iulia Catalina Ferent; Enke Baldini; Salvatore Ulisse; Vito D'Andrea; Daniele Pironi; Salvatore Sorrenti
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

2.  Experimental Modeling of Multiple Primary Malignant Processes with One Tumor Suppressed by Another under Conditions of Primary Immunodeficiency.

Authors:  E M Frantsiyants; I V Kaplieva; L K Trepitaki; E I Surikova; V A Bandovkina; I V Neskubina; I М Коtievа; K А Shumarin
Journal:  Bull Exp Biol Med       Date:  2021-07-24       Impact factor: 0.804

3.  Inhibition of circular RNA_0000285 prevents cell proliferation and induces apoptosis in thyroid cancer by sponging microRNA-654-3p.

Authors:  Rongjun Gao; Hui Ye; Qingjun Gao; Nanpeng Wang; Yan Zhou; Haisong Duan
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.